Updates in Psoriasis - On Demand Webinar

Hear from national experts in this one hour webinar program that addresses the latest updates in psoriasis including latest biologic treatments, burden of disease, comorbidites and much more. 

This activity has been supported by unrestricted educational grants from Valeant, Novartis, and Abbvie. 

If you do not yet have an account with the national psoriasis foundation, please click here to create a new account prior to taking this course. Thank you! 

Accreditation Statement

The National Psoriasis Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit

The National Psoriasis Foundation designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s) TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. 

Target Audience

Dermatologists, Rheumatologists, Allied Health, Primary Care

Learning Objectives

  • Discuss the efficacy and safety of newly approved and promising pipeline therapies for psoriasis, including biologics, small molecule inhibitors, and IL-17 blockade, and how they target various points in the inflammatory pathway.
  • Assess the burden of psoriasis beyond the skin, including associated co-morbid conditions and psychosocial effects
  • Discuss the efficacy, safety and appropriate use of the topical, systemic and biologic therapies currently available for the treatment of psoriasis
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™

    Accreditation

    This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education through the joint providership of Oregon Health & Science University (OHSU) and the National Psoriasis Foundation. OHSU is accredited by the ACCME to provide CME for physicians.

    Credit

    OHSU School of Medicine, Division of CME, designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course opens: 
06/02/2016
Course expires: 
06/01/2018
Cost:
$0.00
Rating: 
0

Jashin Wu, MD, FAAD
Director, Clinical Dermatology
Research Associate Director, Dermatology Residency Program

Jeffrey Weinberg, MD
Associate Clinical Professor, Department of Dermatology
Icahn School of Medicine Attending Physician
Department of Dermatology at Mount Sinai St. Luke’s and Mount Sinai Beth Israel

Accreditation Period

Course opens: 
06/02/2016
Course expires: 
06/01/2018

Price

Cost:
$0.00
Please login to take this course.